Table of Contents
Last reviewed: 21 September 2026 · Sources linked throughout · AAHA & WSAVA-aligned
Checked against the controlled canine challenge and field-trial literature on Bordetella bronchiseptica vaccines (PubMed Central, Veterinary Record, Vaccine, Frontiers, AJVR), the 2017 and 2022 AAHA Canine Vaccination Guidelines, the WSAVA Vaccination Guidelines (2024), the BSAVA position statement, and the Merck Veterinary Manual. Editorial position: the Bordetella vaccine is genuinely useful for at-risk dogs — and genuinely not a magic shield. We tell you exactly what it does, what it doesn’t, and how to choose.
The Bordetella vaccine protects dogs against the main bacterial cause of kennel cough, Bordetella bronchiseptica. Does your dog need it? It depends entirely on lifestyle. Both the American Animal Hospital Association and the WSAVA classify it as a non-core, risk-based vaccine — recommended for dogs that board, attend daycare, visit groomers, go to training classes, dog shows or busy parks, and essential for dogs in shelters. A strictly home-bound dog with little contact with other dogs may not need it at all. It comes in three forms — a nasal spray, an oral liquid, and an injection — and they are not interchangeable. Just as importantly, no Bordetella vaccine is 100% protective: a vaccinated dog can still catch kennel cough, because kennel cough is caused by a whole family of germs and the vaccine only covers some of them. Here is exactly how each type works, what “protection” really means, and how to decide what’s right for your dog.

Key Takeaways
- Non-core, risk-based. AAHA (2017 and 2022) and WSAVA classify the Bordetella vaccine as non-core — given for lifestyle and exposure risk, not to every dog. WSAVA makes it core only for dogs in shelters.
- Three routes, real differences. Intranasal and oral are live vaccines that protect fast (within about 3–7 days) by building immunity right at the airway; injectable is a non-live shot given as two doses in a first-time dog and works through the bloodstream.
- It works. In controlled studies, a single oral or intranasal dose protected dogs from coughing on challenge as early as 7 days, and a single oral dose still protected 13 months later (0 of 17 vaccinated dogs coughed versus 13 of 17 unvaccinated).
- But it is not a guarantee. Kennel cough is caused by many germs working together. No Bordetella vaccine covers canine influenza, canine respiratory coronavirus, Mycoplasma or pneumovirus — so a vaccinated dog can still cough. “Protection” means milder, shorter illness and far less spread, not zero infection.
- Boosters: usually annually, every 6 months for very high-exposure dogs (constant boarding, daycare, show circuit) — often set by the facility.
- Special cases: for flat-faced (brachycephalic) dogs with breathing problems, or homes with a seriously immunocompromised person, the injectable form is often the safer choice.
What’s in this guide
- What is the Bordetella vaccine, and what does it protect against?
- Intranasal vs oral vs injectable: the full comparison
- How well does it actually work? What the studies show
- The honest truth: no Bordetella vaccine is 100%
- Core vs non-core: does my dog really need it?
- How often does my dog need it? The booster schedule
- Side effects: what’s normal and when to call the vet
- How much does the Bordetella vaccine cost?
- Puppies: when to start and why nasal vaccines have an edge
- Special cases: flat-faced breeds and immunocompromised homes
- Frequently asked questions
What is the Bordetella vaccine, and what does it protect against?
The Bordetella vaccine is a kennel cough vaccine. Its job is to prime your dog’s immune system against Bordetella bronchiseptica — the bacterium most strongly associated with kennel cough, the highly contagious respiratory illness that spreads wherever dogs gather. Vets call the broader illness canine infectious respiratory disease complex (CIRDC), and Bordetella is one of its leading players, often working hand-in-hand with viruses to produce that distinctive honking, hacking cough (MSD Veterinary Manual, kennel cough).
Many people call it the “kennel cough shot,” but that phrase hides an important detail: there is no single Bordetella vaccine. There are three quite different products, given three different ways, and some of them also include protection against canine parainfluenza virus (CPiV) and sometimes canine adenovirus type 2 (CAV-2) — two of the viruses that commonly open the door for Bordetella. Which one your dog gets changes how fast it works, how long it lasts, what it covers, and even which dogs it suits. That is why the comparison below is the heart of this guide.
If your dog is already coughing and you are wondering whether it is kennel cough at all, start with our guides to the symptoms of kennel cough and how kennel cough is treated. This page is about prevention — the vaccine decision you make before the cough starts.
“Kennel Cough Vaccine” vs “Bordetella Vaccine”: Sorting Out the Names
Kennel cough is not one illness but a syndrome — now more formally called canine infectious respiratory disease complex (CIRDC) — caused by several different bacteria and viruses, most commonly Bordetella bronchiseptica, canine parainfluenza virus and canine adenovirus type 2 (AVMA; MSD Veterinary Manual). When a vet says “kennel cough vaccine,” they almost always mean the vaccine against Bordetella bronchiseptica — sometimes combined with parainfluenza in the same dose. The 2022 AAHA canine vaccination guidelines are explicit that dogs at risk for Bordetella are also at risk for parainfluenza and adenovirus‑2 and “should be vaccinated for all three pathogens,” noting that only certain combination products cover all three (AAHA 2022).
| Vaccine | What it targets | Where it fits |
|---|---|---|
| “Kennel cough vaccine” (Bordetella) | Bordetella bronchiseptica, often + parainfluenza | Non-core, given separately as a lifestyle vaccine |
| Core DHPP / DA2PP | Distemper, adenovirus, parvovirus + parainfluenza component | Core puppy series + routine boosters — already covers some CIRDC viruses |
| Canine influenza vaccine | Canine influenza virus (H3N2 / H3N8) | Separate, optional vaccine — not routinely given to all dogs |
This means your dog may already have some partial protection against CIRDC viruses through their routine core shots, but they will not be protected against Bordetella specifically unless they receive a Bordetella-containing vaccine (AAHA 2022). Canine influenza is a different virus again, covered only by its own separate vaccine, which the AAHA guidelines classify as non-core and do not recommend routinely for every dog (AAHA 2022). Asking for “the kennel cough shot” does not automatically include influenza cover — the two are separate decisions.
This overlapping terminology is exactly why owners hear different things from different sources. A boarding kennel may simply ask for “kennel cough vaccination within the last year” without specifying route or brand, while UK veterinary guidance from the Royal Veterinary College and Blue Cross both describe the intranasal product specifically as becoming effective within days and lasting around twelve months — useful shorthand, but still just one piece of the bigger picture (RVC; Blue Cross). If you want the fuller picture of what kennel cough itself actually is, beyond the vaccine question, our kennel cough overview and canine cough guide cover the condition in depth.
Intranasal vs oral vs injectable: the full comparison
This is the single most useful thing to understand before you talk to your vet. The three forms of the Bordetella vaccine are not just different ways of giving the same thing — they build immunity in genuinely different ways, with different speeds, durations and trade-offs. Here they are side by side.
| Intranasal (nose drops/spray) | Oral (liquid in the mouth) | Injectable (under the skin) | |
|---|---|---|---|
| How it’s given | Drops or spray into the nostril(s) | Liquid squirted into the cheek pouch | Injection under the skin (subcutaneous) |
| Onset of immunity | Fast — protection demonstrated at 7 days; faster onset is claimed for individual products | Fast — protection by 7 days in a controlled challenge study | Slower — needs two doses 2–4 weeks apart in a first-time dog before full protection |
| Doses in a naive dog | Single dose | Single dose | Two doses, 2–4 weeks apart |
| Duration of protection | ~12 months (annual booster) | Up to ~13 months shown in a challenge study (annual booster) | ~12 months (annual booster); review product leaflet |
| What it covers | Often Bordetella + CPiV + CAV-2 (broadest); some Bordetella-only | Bordetella only (some newer products add CPiV) | Usually Bordetella only |
| Type of immunity | Local mucosal (IgA) right at the airway, plus some whole-body | Mucosal, generated through the mouth/throat lining | Whole-body (systemic IgG) via the bloodstream |
| Live or non-live? | Live, weakened (attenuated) | Live, weakened (attenuated) | Non-live (killed/subunit/bacterin) |
| Typical side effects | Mild sneezing, runny nose, occasional cough for 1–2 days | Minimal | Brief lethargy, mild fever, small lump at the injection site |
| Best for | Most dogs needing broad, fast protection; pre-boarding | Wrigglers who hate having their nose handled; easy administration | Flat-faced dogs with airway issues; homes with an immunocompromised person; dogs that won’t tolerate nasal/oral dosing |
The single biggest divide is where the immunity lives. Intranasal and oral vaccines are designed to build defences right at the mucosal surface — the lining of the nose, throat and airway — which is exactly where Bordetella tries to take hold. That local immunity (rich in a protective antibody called secretory IgA) is why these routes work so quickly and why they are so good at reducing how much bacteria a dog sheds. The injectable vaccine, by contrast, works mainly through the bloodstream, producing whole-body antibodies (IgG) that take longer to build and are a step removed from the airway frontline (Ellis, comparative IN vs injectable anamnestic responses in 144 household dogs, 2017). Neither approach is “wrong” — they simply suit different dogs and different situations, which is what the rest of this guide untangles.

Which Bordetella vaccine is best for my dog?
For most dogs that simply need solid, fast, broad protection before boarding or daycare, an intranasal vaccine that also covers parainfluenza is the workhorse choice — one dose, quick onset, and it tackles more than just Bordetella. The oral route is a brilliant option for dogs who fight having their nose touched, since it is easy to give and avoids the nasal fuss while still building mucosal immunity. The injectable route earns its place in specific situations — flat-faced dogs with compromised airways, households with a seriously immunocompromised person, or dogs that simply will not tolerate nasal or oral dosing — which we cover in detail further down. There is no universally “best” form; the right answer is the one matched to your individual dog.
How well does it actually work? What the studies show
This is where the Bordetella vaccine earns its reputation. Unlike a lot of pet-care advice, the kennel cough vaccine has been put through proper controlled challenge studies — where vaccinated and placebo dogs are deliberately exposed to virulent Bordetella and the outcomes counted. The numbers are genuinely impressive.
Those headline numbers come from three lines of evidence worth knowing about. First, onset: in a beagle challenge study, dogs given a single oral or intranasal dose were challenged with virulent Bordetella just seven days later — and while 8 of 9 placebo dogs developed disease, not a single vaccinated dog in either group did (Scott-Garrard et al., Vet Rec Open 2018, PMC6109801). A second study reported protection within 72 hours of a dose (Gore et al., Veterinary Record 2005) — but that work came from Intervet, the manufacturer of Nobivac, whose own datasheet carries the same 72-hour figure. The 72-hour claim and the datasheet are one source, not two, and seven days remains the independently demonstrated figure.

Second, duration: for years the open question was how long a single dose lasts. A 2020 study answered it for the oral vaccine — dogs were vaccinated once at about eight weeks of age and then challenged a full 13 months later. Thirteen of the 17 placebo dogs developed a spontaneous cough lasting two or more consecutive days; none of the vaccinated dogs did, giving a prevented fraction of 1.000 with a 95% confidence interval of 0.773 to 1.000 (Scott-Garrard et al., 13-month duration of immunity, Veterinary Record Open 2020). A separate study of a live oral vaccine confirmed about a year of protection, with vaccinated dogs coughing for an average of 1.5 days versus 8.6 days in unvaccinated dogs (The Veterinary Journal 2021;278:105775). That evidence is exactly why an annual booster is the standard recommendation.
Third, real-world field results: laboratory challenge is one thing, a chaotic shelter is another. A placebo-controlled trial in dogs entering a humane shelter — about the highest-exposure environment there is — found that two different intranasal vaccines both significantly reduced the incidence of kennel cough compared with placebo (placebo-controlled shelter trial, Vaccine 2004, PMC7126306). And the same 1981 study quantified the shedding benefit: intranasally vaccinated dogs reduced their isolation of virulent Bordetella by 89%, and shed challenge organisms on roughly 1% of the observation days against 70% of days in unvaccinated dogs (Kontor et al., AJVR 1981). The route matters: the parenterally vaccinated dogs in the same experiment shed on 50% of days, so that 1% belongs to the intranasal arm alone. These are figures from one vaccine under experimental aerosol challenge in 1981, not field efficacy for the products on sale today — but the direction, that vaccination cuts what a dog passes on, is the part that has held up.
“Thirteen months after a single oral dose, none of the seventeen vaccinated dogs developed a cough on challenge — while thirteen of seventeen placebo dogs did.”
— Duration-of-immunity challenge study, Veterinary Record Open 2020 (PMC7570226)
The honest truth: no Bordetella vaccine is 100%
Here is the part most articles skip — and it is the part that matters most if you want to make a genuinely informed decision. A vaccinated dog can still catch kennel cough. This is not a sign the vaccine failed; it is a direct consequence of what kennel cough actually is.
Can a vaccinated dog still get kennel cough?
Yes. Kennel cough is not one infection but a polymicrobial complex — a mixed cast of bacteria and viruses, often acting together (Wiechert-Brown et al., oral vaccine duration-of-immunity study, Frontiers in Veterinary Science 2025). The Bordetella vaccine targets Bordetella, plus parainfluenza and adenovirus in some products — but not canine influenza, Mycoplasma cynos, respiratory coronavirus or pneumovirus, so a fully vaccinated dog meeting one of those can still develop a cough. Like most veterinary respiratory vaccines it was also never designed to deliver sterilising immunity, the kind that stops infection ever taking hold: on the evidence above, the realistic promise is that your dog is less likely to catch it, less likely to be seriously ill if it does, and far less likely to pass it on. That is why “not 100% effective” and “strongly recommended” are both true at once.
Is your vaccinated dog coughing right now? The full explanation — which pathogen is likely responsible, the four ordinary reasons a vaccinated dog gets sick anyway, when the cough needs a vet, and how long your dog stays contagious — is in our dedicated guide to kennel cough in vaccinated dogs.
If it’s not 100%, why bother?
Because “reduces severity, duration and spread” is exactly what you want from a contagious illness in a crowded environment. The same is true of most human vaccines we value. For a dog that boards, attends daycare or mixes widely, vaccination means a milder bout if it catches something, a shorter recovery, less risk of the cough progressing to pneumonia, and far less chance of being the dog that sparks a kennel-wide outbreak. The honest framing — useful, not magic — should make you more confident in the decision, not less.
Core vs non-core: does my dog really need it?
Veterinary medicine sorts dog vaccines into two buckets. Core vaccines are recommended for every dog regardless of lifestyle — distemper, adenovirus, parvovirus and rabies. Non-core vaccines are given based on an individual dog’s risk and lifestyle. The Bordetella vaccine sits firmly in the non-core bucket.
Both major guideline bodies agree. The 2017 and 2022 AAHA Canine Vaccination Guidelines list Bordetella (alone or with parainfluenza) under non-core vaccines — vaccines AAHA describes as “just as essential for some dogs based on their lifestyle and risk” (AAHA 2022 Canine Vaccination Guidelines). The 2022 update moved leptospirosis toward core status but kept Bordetella non-core. The WSAVA 2024 Guidelines put it plainly: “Vaccines against respiratory disease are considered non-core for pet dogs living in typical homes but should be considered core for shelter-housed dogs” (WSAVA 2024). In the UK, the BSAVA agrees: vaccination “should be considered for dogs before kennelling or other situations in which they mix with other dogs (e.g. dog shows, training classes)” (BSAVA position statement).
So how do you decide? It comes down to one question: how much does your dog mix with other dogs? The vaccine is recommended for dogs with regular or significant contact — the social, out-and-about dogs — and is reasonably skipped for the genuinely home-bound. Use the table below as a starting point, then confirm with your vet, who can weigh in local outbreak patterns and your dog’s individual health. Bear in mind that the decision is frequently made for you: most boarding kennels, daycares and many groomers require proof of a current Bordetella vaccine, usually given within the last 6–12 months and at least a week or two before arrival.

| Your dog’s lifestyle | Vaccine recommended? |
|---|---|
| Boards at a kennel or attends daycare | Yes — usually required |
| Visits a groomer regularly | Yes — often required |
| Goes to training/socialisation classes, dog shows or sports | Yes — recommended |
| Frequents dog parks or busy walking spots | Yes — recommended |
| Lives in a multi-dog household with out-and-about dogs | Yes — consider for all |
| Lives in a shelter or rescue environment | Yes — core in this setting (WSAVA) |
| Strictly home-bound, single dog, minimal contact with other dogs | Often unnecessary — discuss with your vet |
How often does my dog need it? The booster schedule
How often should a dog get the Bordetella vaccine?
The standard recommendation is an annual booster. The AAHA 2022 vaccine table is explicit: for the intranasal Bordetella-and-parainfluenza vaccine, “a single (IN) dose is indicated for dogs at risk of exposure” with “subsequent boosters annually,” and the same annual interval applies to the oral and injectable forms after their initial series (AAHA 2022 vaccine table). WSAVA’s 2024 table likewise gives the mucosal vaccines a single initial dose and annual revaccination (WSAVA 2024). The 13-month duration-of-immunity data supports annual revaccination comfortably (PMC7570226).
For very high-exposure dogs — those in constant boarding, busy daycare, or on the show circuit — many vets and facilities move to a 6-monthly booster. It is worth being honest about where that recommendation comes from: it is driven more by facility policy and a precautionary margin than by a hard guideline requirement, since the controlled-study data shows protection lasting a year or more. If your daycare or boarding kennel asks for a 6-month booster, that is their prerogative as a condition of entry, and there is no harm in it — but a typical socially-active pet dog is well served by the annual schedule. One more practical point: give the booster 10–14 days before a boarding stay or event so immunity is fully established by the time your dog arrives (UTCVM Vaccination Protocol).
Side effects: what’s normal and when to call the vet
The Bordetella vaccine is considered very safe, and the great majority of dogs sail through it with nothing more than a mild, brief reaction — often a sign the immune system is doing exactly what it should. The pattern depends on the route. (For the full picture, see our dedicated, in-depth guide to Bordetella vaccine side effects; here is everything you need to recognise the normal from the worrying.)

After the intranasal or oral vaccine, some dogs develop mild, cold-like signs for a day or two: a little sneezing, a runny nose, or an occasional cough. This is expected with a live mucosal vaccine and almost always settles on its own within 48 hours. After the injectable vaccine, the typical reaction is a quiet half-day or day — mild lethargy, a slightly reduced appetite, perhaps a very mild fever — and sometimes a small, firm, tender lump at the injection site that resolves over a few days. None of this needs treatment; a calm spot to rest and a normal routine is all most dogs require.
Call the vet — or seek emergency care — if you see:
- Swelling of the face or muzzle, hives, or intense itching — signs of an allergic reaction
- Vomiting or diarrhoea shortly after vaccination
- Difficulty breathing, collapse or sudden weakness — this is a veterinary emergency
- Mild signs (sneezing, lethargy, a runny nose, an injection-site lump) that last more than two days or are getting worse rather than better
- An injection site that becomes very painful, hot, or starts to ooze
True anaphylactic (severe allergic) reactions are extremely rare, but they tend to appear within minutes to a few hours of the vaccine — occasionally up to 48 hours later. If you ever see facial swelling, breathing trouble or collapse, contact an emergency vet immediately; these reactions respond well to prompt treatment.
A few dogs are better off skipping or delaying the vaccine: those who are already unwell, have a history of vaccine reactions, or are pregnant or nursing. The injectable form has a minimum age of 6 weeks in the UK (Nobivac Respira Bb datasheet) and 8 weeks in the US (Vanguard B Injectable label), whereas the intranasal vaccine can be given to very young puppies — which brings us neatly to the puppy schedule.
How much does the Bordetella vaccine cost?
How much is a Bordetella vaccine for a dog?
The Bordetella vaccine is one of the more affordable pieces of preventive care. In the United States, the shot itself typically runs $15–$50, most commonly around $30–$40 at a full-service clinic. Add a routine exam fee and the full visit usually lands somewhere between $35 and $95. At low-cost vaccine clinics, humane societies and community events, the price drops sharply — often $10–$20 for the vaccine alone, and sometimes bundled into a discounted package with core vaccines and a microchip. In the United Kingdom, the kennel cough vaccine (commonly the intranasal Bordetella-plus-parainfluenza product) is usually priced in the region of £25–£45 at general practice, and is frequently a condition of boarding. (Prices vary by region and clinic; treat these as typical ranges, and see our full breakdown of Bordetella vaccine costs.)
It is worth putting that figure next to the alternative. Treating a serious case of kennel cough that progresses — with veterinary visits, chest X-rays, and a course of medication for the cough or antibiotics — costs many times more than the vaccine, before you even count the discomfort to the dog. For a dog that genuinely mixes with others, the maths is straightforward.
Puppies: when to start and why nasal vaccines have an edge
When can a puppy get the Bordetella vaccine?
Earlier than you might expect. Depending on the product, the intranasal vaccine can be given to puppies from as early as 3 weeks of age, and can go in alongside the core puppy shots, which start at 6–8 weeks (UTCVM Vaccination Protocol); the puppy vaccination schedule sets out the timing in full. The oral vaccine is generally started from 8 weeks. The injectable vaccine is licensed from 6 weeks in the UK, where Nobivac Respira Bb is given as two doses four weeks apart, and from 8 weeks in the US, where Vanguard B Injectable is given as two doses 2–4 weeks apart. Either way, a first-time puppy needs both doses to build full protection. For puppy socialisation classes, aim to have the vaccine in at least a week or two before the first session.

Here is the clever bit, and it is the best argument for the nasal and oral routes in young puppies. Newborn pups absorb antibodies from their mother’s first milk — these maternally derived antibodies (MDA) are protective, but they are a double-edged sword: they can also neutralise an injected vaccine before the puppy’s own immune system gets to respond. This is the reason core puppy vaccines have to be given as a series of shots up to about 16 weeks, until maternal antibodies fade (MSD Veterinary Manual).
Mucosal vaccines sidestep the problem. Because the intranasal and oral Bordetella vaccines build immunity locally at the airway surface — rather than relying on antibodies circulating in the blood — they are far less affected by maternal antibodies, and can work in a young puppy even when an injected vaccine might be blocked (Day, immune system development in the dog, J Comp Pathol 2007). Combine that with protection demonstrated seven days after a single dose, and the intranasal vaccine can give a young, socially-active puppy meaningful protection. That is why so many vets reach for the nasal or oral route first in puppyhood. (A full puppy vaccination-schedule guide is part of our wider series; for puppy-specific kennel cough advice now, see our guide to kennel cough in puppies.)
Special cases: flat-faced breeds and immunocompromised homes
Flat-faced (brachycephalic) dogs — is the injectable safer?
Flat-faced breeds — Bulldogs, French Bulldogs, Pugs and their relatives — often have compromised airways and reduced breathing reserve, sometimes amounting to brachycephalic obstructive airway syndrome (BOAS). In these dogs, even mild airway inflammation or extra mucus can tip them toward respiratory distress (Packer & Tivers, Veterinary Journal 2015). Because the live intranasal and oral vaccines can cause transient sneezing, nasal discharge and the odd cough, many vets prefer the injectable form for flat-faced dogs with significant breathing problems — it builds immunity without stirring up the airway. This is a sensible risk-benefit judgement based on how these dogs are built rather than on breed-specific vaccine trials, so it is exactly the kind of decision to talk through with your own vet.
If someone in the home is immunocompromised
This is a nuance most articles miss, and it genuinely matters. The live intranasal vaccine contains a weakened but living strain of Bordetella, and a vaccinated dog sheds that strain for considerably longer than most owners are told: the Nobivac KC datasheet puts it at up to six weeks, and advises immunocompromised people to avoid contact with the vaccine and with vaccinated animals for that whole period. Bordetella bronchiseptica is a recognised — if rare — cause of infection in people whose immune systems are seriously compromised, such as those on chemotherapy, transplant medication or with advanced HIV (Woolfrey & Moody, human B. bronchiseptica review, Clin Microbiol Rev 1991). For that reason, when a severely immunocompromised person lives in the household, vets often recommend the injectable, non-live Bordetella vaccine — it contains no living organism, so there is nothing to shed (subcutaneous bacterial-ghost vaccine in dogs, Front Immunol 2019). The dog still gets protected, and the shedding is removed. The human risk is not merely theoretical: a 2023 report describes the first confirmed dog-to-human transmission of a vaccine strain, in a patient taking an immune-suppressing drug, and cites a European Medicines Agency position advising against vaccinating the animals of people with impaired immunity. If this applies to your home, raise it with your vet before the appointment. We cover the human side of this in our guide to whether kennel cough is contagious to humans.
One reassuring footnote for owners of working and scent dogs: a study of detection dogs found that oral or intranasal Bordetella vaccination did not impair their olfactory performance — so a nasal vaccine won’t blunt your dog’s nose (Otto et al., Front Vet Sci 2022).
What the Vaccine Doesn’t Replace
No vaccine closes every gap, and the CIRDC literature says so plainly: protective immunity against respiratory disease is “rarely complete”, and vaccination generally achieves a reduction in clinical signs and in how much pathogen a dog sheds rather than outright prevention (Day et al., J Comp Pathol 2020). The same review describes control of kennel cough as vaccination plus the conditions dogs are kept in — “sanitation, population density, ventilation and quarantine procedures” — rather than vaccination on its own. For an owner that means everyday hygiene, keeping a coughing dog away from others until they have recovered, and sensible exposure management when there is a local outbreak. One further observation is ours rather than any source’s: the better boarding and daycare facilities layer their own cleaning, ventilation and isolation protocols on top of a vaccination requirement — which is what you would expect if no single measure closes every gap on its own. Our guide to preventing kennel cough covers the practical, non-vaccine side of this, and how long kennel cough is contagious explains how long to keep a coughing dog isolated from others.
Frequently asked questions
Does my dog really need the Bordetella vaccine?
It depends on lifestyle. It is recommended for dogs that board, attend daycare, visit groomers, go to classes, shows or busy parks, or live in shelters. A strictly home-bound dog with little dog-to-dog contact may not need it — though most boarding and daycare facilities require it regardless. Both AAHA and WSAVA classify it as a non-core, risk-based vaccine.
Can a vaccinated dog still get kennel cough?
Yes. Kennel cough is caused by many germs, and the Bordetella vaccine only covers Bordetella (and sometimes parainfluenza and adenovirus). It does not cover canine influenza, respiratory coronavirus, Mycoplasma or pneumovirus. A vaccinated dog can still catch a cough from one of those — but vaccination makes any illness milder and shorter, and greatly reduces how much the dog spreads it.
How often does a dog need the Bordetella vaccine?
Annually for most dogs, after the initial series. Very high-exposure dogs (constant boarding, daycare, show circuit) are often boosted every 6 months, frequently as a facility requirement. Give the booster 10–14 days before boarding so immunity is fully established.
What’s the difference between the nasal, oral and injectable vaccines?
The intranasal and oral vaccines are live and build fast, local airway immunity from a single dose; the intranasal version often also covers parainfluenza. The injectable vaccine is non-live, works through the bloodstream, needs two doses in a first-time dog, and is the preferred choice for flat-faced dogs with airway problems or homes with an immunocompromised person.
How long does it take for the Bordetella vaccine to work?
Fast for the mucosal routes. In controlled studies, single oral and intranasal doses protected dogs as early as 7 days after vaccination, and one intranasal product protected within 72 hours. The injectable form is slower and needs its two-dose series completed first. As a rule of thumb, vaccinate at least 1–2 weeks before exposure.
What are the side effects of the Bordetella vaccine?
Usually mild and brief. Nasal and oral vaccines may cause a day or two of sneezing, runny nose or a light cough; the injectable form may cause short-lived lethargy, a mild fever or a small injection-site lump. Serious allergic reactions (facial swelling, hives, breathing trouble, collapse) are extremely rare but need emergency care.
How much does the Bordetella vaccine cost?
In the US, typically $15–$50 for the shot (often $30–$40 at a vet, $10–$20 at a low-cost clinic), plus any exam fee. In the UK, roughly £25–£45 at general practice. It is one of the cheapest pieces of preventive care, and far less than treating a serious case.
Can puppies have the Bordetella vaccine?
Yes. The intranasal vaccine can be given to puppies from as early as 3 weeks, the oral from 8 weeks, and the injectable from 6 weeks (UK) or 8 weeks (US), depending on the product, as a two-dose series. Mucosal (nasal/oral) vaccines have an advantage in young puppies because they are less likely to be blocked by maternal antibodies.
Is the Bordetella vaccine safe?
Yes — it has an excellent safety record and decades of use. Most dogs have no reaction or only a mild, brief one. As with any vaccine, serious reactions are possible but extremely rare, and the benefit for at-risk dogs comfortably outweighs the small risk. Dogs that are unwell, pregnant or have a history of vaccine reactions should be assessed individually by a vet.
Where to read next
- Kennel Cough: The Complete Guide — the full picture of what kennel cough is, how it spreads, and how it’s managed.
- Kennel Cough Symptoms — how to recognise the cough and judge how serious it is.
- Kennel Cough Treatment — what actually helps a coughing dog recover.
- Kennel Cough in Puppies — why puppies need extra care and when to worry.
- Is Kennel Cough Contagious to Humans? — the rare human risk, and the vaccine-strain nuance for immunocompromised households.
One last word. The Bordetella vaccine is a genuinely useful, well-studied, low-cost tool — not a guarantee, but a real reduction in how often your dog gets sick, how badly, and how much it spreads. For a social, out-and-about dog, it is one of the easiest preventive wins there is. For a quiet home-body, it may be unnecessary. The honest answer for your dog comes from a two-minute conversation with your vet, who can weigh your dog’s lifestyle, breed and health against what’s circulating locally — and now you’ll be walking into that conversation knowing exactly what to ask.



